BIOMAT Database Logo BIOMAT Database Logo

OPC-13340, a new dihydropyridine calcium channel blocker attenuates rapid vascular smooth muscle cell growth in spontaneously hypertensive rats. 1992

Y Uehara, and Y Kawabata, and N Hirawa, and S Takada, and A Numabe, and H Matsuoka, and T Ikeda, and Y Takabatake, and S Yagi, and T Sugimoto
2nd Department of Medicine, University of Tokyo, Japan.

We investigated the mechanism of the antimitotic effects of calcium channel blockers in vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR). VSMC from SHR exhibited rapid proliferation through a quick transition from the G0/G1 to the DNA synthetic (S) phase and from the S to the G2/mitotic (M) phase, whereas the DNA synthetic rate itself was equal to that of Wistar-Kyoto rats (WKY). OPC-13340, a new dihydropyridine calcium channel blocker, dose-dependently decreased incorporation of [3H]thymidine into the DNA fragments in randomly cycling VSMC in SHR. Cell cycle analysis showed that the rapid transition from the S to the G2/M period was restored by OPC-13340 to the control level in WKY, whereas the quick transition from G0/G1 to S was unaffected. This antimitotic effect of OPC-13340 was reflected by attenuation of enhanced cellular protein synthesis during the G2/M period. Protein synthesis in the G0/G1 period was not influenced by OPC-13340. Thus, these data indicate that the calcium channel blocker OPC-13340 mitigates the enhanced proliferation observed in randomly cycling VSMC from SHR and that this effect is primarily due to normalization of the premature mitosis during the G2/M period.

UI MeSH Term Description Entries
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004095 Dihydropyridines Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA

Related Publications

Y Uehara, and Y Kawabata, and N Hirawa, and S Takada, and A Numabe, and H Matsuoka, and T Ikeda, and Y Takabatake, and S Yagi, and T Sugimoto
Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
January 1993, Archives internationales de pharmacodynamie et de therapie,
Y Uehara, and Y Kawabata, and N Hirawa, and S Takada, and A Numabe, and H Matsuoka, and T Ikeda, and Y Takabatake, and S Yagi, and T Sugimoto
Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats.
May 1990, Journal of cardiovascular pharmacology,
Y Uehara, and Y Kawabata, and N Hirawa, and S Takada, and A Numabe, and H Matsuoka, and T Ikeda, and Y Takabatake, and S Yagi, and T Sugimoto
Effects of the L- and N-type calcium channel blocker cilnidipine on growth of vascular smooth muscle cells from spontaneously hypertensive rats.
September 2001, Journal of cardiovascular pharmacology,
Y Uehara, and Y Kawabata, and N Hirawa, and S Takada, and A Numabe, and H Matsuoka, and T Ikeda, and Y Takabatake, and S Yagi, and T Sugimoto
Calcium channels in the vascular smooth muscle of spontaneously hypertensive rats.
December 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
Y Uehara, and Y Kawabata, and N Hirawa, and S Takada, and A Numabe, and H Matsuoka, and T Ikeda, and Y Takabatake, and S Yagi, and T Sugimoto
Multiple growth abnormalities in vascular smooth muscle from spontaneously hypertensive rats.
May 1991, Clinical and experimental pharmacology & physiology,
Y Uehara, and Y Kawabata, and N Hirawa, and S Takada, and A Numabe, and H Matsuoka, and T Ikeda, and Y Takabatake, and S Yagi, and T Sugimoto
Natriuretic action of manidipine hydrochloride, a new calcium channel blocker, in spontaneously hypertensive rats.
October 1989, Japanese journal of pharmacology,
Y Uehara, and Y Kawabata, and N Hirawa, and S Takada, and A Numabe, and H Matsuoka, and T Ikeda, and Y Takabatake, and S Yagi, and T Sugimoto
Abnormal calcium handling in vascular smooth muscle cells of spontaneously hypertensive rats.
April 1990, Journal of hypertension,
Y Uehara, and Y Kawabata, and N Hirawa, and S Takada, and A Numabe, and H Matsuoka, and T Ikeda, and Y Takabatake, and S Yagi, and T Sugimoto
Intracellular sodium and calcium in vascular smooth muscle of spontaneously hypertensive rats.
January 1984, Journal of cardiovascular pharmacology,
Y Uehara, and Y Kawabata, and N Hirawa, and S Takada, and A Numabe, and H Matsuoka, and T Ikeda, and Y Takabatake, and S Yagi, and T Sugimoto
Nisoldipine: a new dihydropyridine calcium-channel blocker.
January 1993, Journal of clinical pharmacology,
Y Uehara, and Y Kawabata, and N Hirawa, and S Takada, and A Numabe, and H Matsuoka, and T Ikeda, and Y Takabatake, and S Yagi, and T Sugimoto
Effects of CV-4093, a new dihydropyridine calcium channel blocker, on renal hemodynamics and function in stroke-prone spontaneously hypertensive rats (SHRSP).
October 1989, Japanese journal of pharmacology,
Copied contents to your clipboard!